DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slid 2.19% to $48.66 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.94% to 6,033.11 and the Dow Jones Industrial Average rising 0.75% to 42,515.09.
This was the stock's second consecutive day of losses.
Bristol Myers Squibb Co. closed 23.16% below its 52-week high of $63.33, which the company reached on March 11th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.20% to $155.22, Pfizer Inc. $(PFE)$ fell 0.57% to $24.40, and Abbott Laboratories $(ABT)$ fell 1.19% to $134.01.
Trading volume (14.9 M) remained 340,943 below its 50-day average volume of 15.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 16, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 16, 2025 16:39 ET (20:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。